Topical steroid damaged skin: A clinico-epidemiological and dermatological study
DOI:
https://doi.org/10.66344/jpad.v31i3.1621Keywords:
topical steroid, adverse effect, dermoscopy, Potency, abuse, erythema, white hairAbstract
Objective To evaluate patients clinically diagnosed as having topical steroid damaged skin clinically as well as by dermoscopy. To tabulate the common side effects observed, source and potency of the steroid used.
Methods A thorough history, clinical evaluation, photography and dermoscopy of lesions performed. Details entered in a structured 14 point questionnaire.
Results 189 patients were studied. Common diagnoses which led to steroid abuse were dermatophytosis (40.2%), pigmentary abnormalities, (30.1%) and acne scars (12.1%). Dermatologists (51.2%) and pharmacists (21.2%) were the foremost prescribers; The average duration of use was 2 weeks to 2 years. The common steroids abused were betamethasone (34%), mometasone (28%), clobetasol and halobetasol derivatives. Common side effects included erythema, hypopigmentation, tinea incognito, striae, atrophy and visible veins. White to translucent hairs admixed with the normal pigmented vellus facial hair was a novel dermatoscopic observation. Early changes of TSDS in users of less than four weeks were found to be erythema and hypopigmentation which on dermatoscopy showed loss of rete pigmentary network, tortuous dilated vessels with brown clods and white to pink structureless zones.
Conclusion Topical steroid damaged skin is a common dermatological concern. Dermoscopy can be used to detect early steroid induced changes to prevent its further unmonitored use and side effects along with creating awareness in general population about potential harm of indiscriminate use.
Key words
Topical steroid, adverse effect, dermoscopy, potency, abuse, erythema, white hair.
References
1. Sulzberger MB, Witten VH. The effect of topically applied compound F in selected dermatoses. J Invest Dermatol.1952; 19:101-2.
2. Mahe A, Ly F, Aymard G, Dangou JM. Skin diseases associated with the cosmetic use of bleaching products in women from Dakar, Senegal. Br J Dermatol.2003;148:493-500
3. Becker DE. Basic and clinical phar macolog y of glucocorticosteroids. Anesth Prog.2013;60:25–31
4. Abraham A, Roga G. Topical steroid-damaged skin. Indian J Dermatol. 2014;59:456-9
5. Gómez Moyano E, Crespo Erchiga V, Martínez Pilar L, Martinez García S. Correlation between dermoscopy and direct microscopy of morse code hairs in tinea incognito. J Am Acad Dermatol.2016;74(1):e7-8. doi: 10.1016/j.jaad.2015.09.019.
6. Lallas A, Argenziano G, Longo C, Moscarella E, Apalla Z, Koteli C, et al. Polygonal vessels of rosacea are highlighted by dermoscopy. Int J Dermatol. 2014;53:e325–7.
7. Kittler H, Marghoob AA, Argenziano G, Carrera C, Curiel-Lewandrowski C, Hofmann-Wellenhof R, Malvehy J, Menzies S, Puig S, Rabinovitz H, Stolz W. Standardization of terminology in dermoscopy/dermatoscopy: Results of the third consensus conference of the International Society of Dermoscopy. J Am Acad Dermatol.2016;74(6):1093-106.
8. Lu H, Xiao T, Lu B, Dong D, Yu D, Wei H, et al. Facial corticosteroid addictive dermatitis in Guiyang city, China. Clin Exp Dermatol.2009;35:618-21.
9. Al-Dhalimi MA, Aljawahiri N. Misuse of topical corticosteroids: A clinical study from an Iraqi hospital. East Mediterr Health J. 2006;12:847-52
10. Nagesh T S, Akhilesh A. Topical steroid awareness and abuse: A prospective study among dermatology outpatients. Indian J Dermatol.2016;61:618-21. Available from: http://www.eijd.org/text.asp?2016/61/6/618/193666
11. Saraswat A, Lahiri K, Chatterjee M, Barua S, Coondoo A, Mittal A, et al. Topical corticosteroid abuse on the face: A prospective, multicenter study of dermatology outpatients. Indian J Dermatol Venereol Leprol.2011;77:160-6
12. Rapaport MJ, Rapaport V. The Red Skin Syndromes: Corticosteroid addiction and withdrawal. Expert Rev Dermatol. 2006;1:547–61
13. Friedman P, Sabban EC, Cabo H. Usefulness of dermoscopy in the diagnosis and monitoring treatment of demodicidosis. Dermatol Pract Concept.2017;7(1):35-8. doi:10.5826/dpc.0701a06.
14. Hengge UR, Ruzicka T, Schwartz RA, Cork MJ. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol. 2006;54:1–15
15. Jakhar D and Kaur I. Dermoscopy of topical steroid damaged/dependent skin. Indian Dermatol Online J.2018;9:286-7.
16. Kaliyadan F, Jha AK, Sonthalia S. Dermoscopy of striae rubrae. Indian Dermatol Online J.2018;9(6):477.
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Surya Ravindran, Smitha S Prabhu, Sudhir UK Nayak
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
